Sonio, an AI-powered prenatal screening solution, secured €14 million in Series A funding. The startup aims to improve prenatal care through advanced AI technologies, potentially revolutionising the field of maternal-fetal medicine.

Sonio develops AI algorithms that analyse fetal ultrasound images to detect potential abnormalities and provide decision support for healthcare professionals. The company’s technology has the potential to enhance the accuracy and efficiency of prenatal screenings, leading to better outcomes for both mothers and babies. This funding will likely be used to further develop Sonio’s AI capabilities and expand its market presence.

Additional reading: Axios https://www.axios.com/pro/health-tech-deals/2023/07/11/sonio-raises-14m-series-a-for-prenatal-screening